PDF(1299 KB)
PDF(1299 KB)
PDF(1299 KB)
儿童不完全川崎病的临床特点分析
Clinical features of children with incomplete Kawasaki disease
目的 探讨不完全川崎病 （IKD）患儿的临床特点，为早期诊断该病提供可借鉴的经验。方法 回顾性分析22例住院IKD患儿的临床资料，并与同期住院的63例川崎病 （KD）患儿和20例发热患儿进行对比研究。结果 所有患儿均有发热，IKD组患儿的肢端变化、结膜充血及颈部淋巴结肿大的发生比例均显著低于KD组 （均P < 0.05）；且IKD组患儿的血清谷丙转氨酶显著高于KD组 （P < 0.05），而血浆白蛋白、血清钠、白介素6水平均显著低于KD组 （均P < 0.05）。IKD组丙球使用率与KD组无差异，而IKD组冠脉损害的发生率却显著高于KD组 （P < 0.05）。结论 IKD患儿的症状体征均不典型。肝功能检测及血钠、白介素6水平检测可能有助于IKD的诊断。
Objective To investigate the clinical features of children with incomplete Kawasaki disease (IKD), and to provide reference for the early diagnosis of IKD. Methods The clinical data of 22 hospitalized children with IKD were analyzed retrospectively and compared with the data of 63 children with Kawasaki disease (KD) who were hospitalized during the same period of time. Another 20 children with pyrexia were enrolled as the control group. Results Pyrexia was observed in all children. Compared with the KD group, the IKD group had significantly lower proportions of children with changes in the limbs, conjunctival hyperaemia, and cervical lymphadenectasis (P < 0.05), a significantly higher serum level of glutamic-pyruvic transaminase (P < 0.05), and significantly lower levels of plasma albumin, serum sodium, and interleukin-6 (P < 0.05). There was no significant difference in the rate of γ-globulin application between the IKD and KD groups; however, the IKD group had a significantly higher incidence rate of coronary artery lesion than the KD group (P < 0.05). Conclusions The symptoms and signs in children with IKD are untypical. The liver function test and serum hyponatremia and IL-6 measurements may be useful for the diagnosis of IKD.
Incomplete Kawasaki disease / Clinical feature / Risk factor / Child
[1] Choi Y,Eun LY,Oh SH.Incomplete Kawasaki disease in a 12-month-old girl presenting with cardiac murmur and iron deficiency anemia[J].Pediatr Int,2016,58(5):377-379.
[2] Sánchez-Manubens J,Bou R,Anton J.Diagnosis and classification of Kawasaki disease[J].J Autoimmun,2014,48-49:113-117.
[3] Yeom JS,Woo HO,Park JS,et al.Kawasaki disease in infants[J].Korean J Pediatr,2013,56(9):377-382.
[4] 马春利,薛满.MMP-1、IL-6及VEGF与川崎病患儿冠状动脉损伤的关系[J].医学综述,2014,20(21):3966-3968.
[5] Ebbeson RL,Riley MR,Potts JE,et al.Kawasaki disease at British Columbia's Children's Hospital[J].Paediatr Child Health,2004,9(7):466-470.
[6] Tseng WN,Lo MH,Guo MM et al.IL-31 associated with coronary artery lesion formation in Kawasaki disease[J].PLoS One,2014,9(8):e105195.
[7] Shah V,Christov G,Mukasa T,et al.Cardiovascular status after Kawasaki disease in the UK[J].Heart,2015,101(20):1646-1655.
[8] Newburger JW,Takahashi M,Beiser AS,et al.A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome[J].N Engl J Med,1991,324(23):1633-1639.
[9] Tacke CE,Breunis WB,Pereira RR et al.Five years of Kawasaki disease in the Netherlands:a national surveillance study[J].Pediatr Infect Dis J,2014,33(8):793-797.
[10] 付培培,杜忠东,潘岳松.单中心9年不完全川崎病回顾性分析[J].中国循证儿科杂志,2012,7(4):293-297.
[11] Liu L,Yin W,Wang R,et al.The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease:a meta-analysis[J].Inflamm Res,2016,65(2):161-168.
[12] 张远达,李荣敏,冀超玉,等.川崎病患儿25-羟基维生素D3水平变化及意义[J].中国当代儿科杂志,2016,18(3):211-214.
[13] 史翠平,张宏艳.TGFBR2基因多态性与川崎病和冠状动脉损伤相关性的研究[J].中国当代儿科杂志,2013,15(9):767-770.
[14] 罗泽民,樊映红,刘德松.不完全川崎病的早期诊断和临床特征[J].实用儿科临床杂志,2011,26(9):671-673.
[15] Sudo D,Monobe Y,Yashiro M,et al.Coronary artery lesions of incomplete Kawasaki disease:a nationwide survey in Japan[J].Eur J Pediatr,2012,171(4):651-656.
[16] Takahara T,Shimizu M,Nakagishi Y,et al.Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease[J].Rheumatol Int,2015,35(1):81-84.
